Demystifying the Global Registries Landscape — Emerging Regulations in Key Markets
Video
薬事規制関連支援サービス
CTIS, EMA Policy 70, global registry requirements: Master data disclosure, transparency and lay summaries best practice with guidance from Citeline expert Thomas Wicks.
There are consequences for (disclosure) noncompliance.
特別講演者
Thomas Wicks
Head of Transparency Operations, Citeline
Thomas Wicks is an experienced strategic leader with over 20 years in life sciences. As Head of Transparency Operations at Citeline, he spearheads strategy for TrialScope's industry-leading disclosure solutions. Thomas is an established thought leader, having spoken at over 60 conferences and authored over 40 publications on disclosure requirements and transparency trends. Thomas is motivated by empowering teams to accelerate solutions that honor trial transparency.
JUL 10, 2024
Article
薬事規制関連支援サービス
Clinical Data Transparency a Big Challenge for Smaller Sponsors
Many smaller organizations have not yet implemented a specialized clinical trial disclosure system. Robust transparency, and perhaps even just compliance with multiple regulators, requires commitment from the C-suite for companies of all sizes.